drugset / Trial / NCT00033839

A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache

NCT00033839 ↗

Phase 3 Completed 60 enrolled Winston Laboratories
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).

Timeline

Start
2002-01
Primary completion
2003-07
Completion
2003-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Zucapsaicin Small molecule — Intranasal